Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W32
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,412
Award facts
- Contract value 100% obligated
- $61,412.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 21, 2026, provides Zepbound 5 mg/0.5 mL pen injections to the Defense Logistics Agency (DLA) through AmerisourceBergen Drug Corp, the pharmaceutical distribution subsidiary of Cencora, Inc. The $61,412.23 firm fixed-price order is non-competitive and utilizes an existing Indefinite Delivery Contract (IDC) vehicle. Performance will be completed by January 22, 2026, with fulfillment from AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist used for weight management, reflecting the expanding scope of pharmaceutical products supplied through federal medical procurement channels.
This delivery order is executed under AmerisourceBergen's substantial $999,999,999 IDC with DLA Troop Support Medical, which extends through December 2026 and serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare programs globally. The IDC encompasses a comprehensive range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As the prime contractor on this vehicle, AmerisourceBergen leverages its critical position in the federal medical supply chain to support the Defense Health Agency and other government healthcare systems, with this particular delivery order representing a routine task order fulfilling ongoing pharmaceutical requirements for military treatment facilities.
Quick answers
Who was awarded contract SPE2DR26F1W32?
SPE2DR26F1W32 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1W32 worth?
The government has obligated $61,412 on SPE2DR26F1W32.
Is contract SPE2DR26F1W32 an order under another contract?
Yes. SPE2DR26F1W32 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W32 competed?
The extent of competition for SPE2DR26F1W32 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award